16. J Inorg Biochem. 2018 Apr 9. pii: S0162-0134(17)30881-4. doi:10.1016/j.jinorgbio.2018.04.006. [Epub ahead of print]Anti-cancer activity of di- and tri-organotin(IV) compounds withD-(+)-Galacturonic acid on human tumor cells.Attanzio A(1), Ippolito M(1), Girasolo MA(1), Saiano F(2), Rotondo A(3), RubinoS(1), Mondello L(4), Capobianco ML(5), Sabatino P(6), Tesoriere L(7), CasellaG(8).Author information: (1)Dipartimento di Scienze e Tecnologie Biologiche Chimiche e Farmaceutiche(STEBICEF), Università degli Studi di Palermo, Parco d'Orleans II, Viale delleScienze, Edificio 16, 90128 Palermo, Italy.(2)Dipartimento di Scienze Agrarie, Alimentari e Forestali, Università degliStudi di Palermo, Parco d'Orleans II, Viale delle Scienze, Edificio 4, 90128Palermo, Italy.(3)Dipartimento di Scienze Biomediche, Odontoiatriche e delle ImmaginiMorfologiche e Funzionali- Università di Messina, A.O.U. Policlinico "G. Martino"Via Consolare Valeria, pad. G, Torre biologica, 98125 Messina, Italy.(4)Dipartimento di Scienze Chimiche, Biologiche, Farmaceutiche ed Ambientali,Università di Messina, Stagno d'Alcontres, 31-98166 Messina, Italy.(5)ISOF - CNR Area della Ricerca di Bologna, Via P. Gobetti 101-40129 Bologna,Italy.(6)Dipartimento di Chimica "Giacomo Ciamician", Alma Mater Studiorum, Università degli Studi di Bologna, via F. Selmi 2, 40126 Bologna, Italy.(7)Dipartimento di Scienze e Tecnologie Biologiche Chimiche e Farmaceutiche(STEBICEF), Università degli Studi di Palermo, Parco d'Orleans II, Viale delleScienze, Edificio 16, 90128 Palermo, Italy. Electronic address:luisa.tesoriere@unipa.it.(8)Dipartimento di Scienze della Terra e del Mare (DiSTeM), Università degliStudi di Palermo, Via Archirafi 10, 90123 Palermo, Italy; ConsorzioInteruniversitario di Ricerca in Chimica dei Metalli nei Sistemi Biologici(C.I.R.C.M.S.B.), Piazza Umberto I, 70121 Bari, Italy. Electronic address:girolamo.casella@unipa.it.We have compared the anti-proliferative activity in vitro, of R2SnGala (1-3)[R = Me, n-Bu, Ph] and novel R3SnGala (4, 5) [R = Me, n-Bu] withD-(+)-Galacturonic acid [HGala; Galaq-, q = (2) and (1) for R2SnGala andR3SnGala, respectively] compounds, towards human tumor cell lines of intestinalcarcinoma (HCT-116) and breast adenocarcinoma (MCF-7). The new synthesized 4 and 5 compounds were characterized, in solution, by 1H, 13C and 119Sn NMR, thatshowed that HGala acts as monoanionic moiety and evidenced the dynamic behaviorof the compounds, due to inter-conversions involving the anomeric carbon atom of the ligand. Cell viability, apoptosis induction and cell cycle distribution were analyzed by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT)colorimetric assay and flow cytometry, respectively. The cytotoxicity of thecompounds, in the micro-submicromolar range, changed in the order of theorganotin(IV) moieties, according to 5 > 3 > 2, while 1 and 4, containingMenSn(IV) (n = 2,3) moieties, were ineffective. Compound 5 showed peculiarcytotoxic effects. It did not cause time dependent inhibition of cell growth nor accumulated into the cells. Cell death induced by the active 2, 3, and 5, wasshown to be apoptotic by measuring the exposure of phosphatidylserine to theouter membrane and the loss of mitochondrial potential. All the cytotoxiccompounds induced an accumulation of cells in the subG0/G1phase, while only 2 and3 perturbed the cell cycle confining viable cells in G0/G1phase. Finally, none ofthe compounds investigated affected the viability of normal intestinal or livercells, indicating selectivity towards tumor cells.Copyright © 2018. Published by Elsevier Inc.DOI: 10.1016/j.jinorgbio.2018.04.006 PMID: 29807841 